DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Li N, Cai H, Jiang L. et al.
Enzyme-sensitive and amphiphilic PEGylated dendrimer-paclitaxel prodrug-based nanoparticles for enhanced stability and anticancer efficacy.
ACS Appl Mater Interfaces 2017;
9 (08) 6865-6877
We do not assume any responsibility for the contents of the web pages of other providers.